260972-16-5Relevant articles and documents
Antagonists of the human adenosine A2A receptor. Part 1: Discovery and synthesis of thieno[3,2-d]pyrimidine-4-methanone derivatives
Gillespie, Roger J.,Adams, David R.,Bebbington, David,Benwell, Karen,Cliffe, Ian A.,Dawson, Claire E.,Dourish, Colin T.,Fletcher, Allan,Gaur, Suneel,Giles, Paul R.,Jordan, Allan M.,Knight, Antony R.,Knutsen, Lars J.S.,Lawrence, Anthony,Lerpiniere, Joanne,Misra, Anil,Porter, Richard H.P.,Pratt, Robert M.,Shepherd, Robin,Upton, Rebecca,Ward, Simon E.,Weiss, Scott M.,Williamson, Douglas S.
, p. 2916 - 2919 (2008/12/22)
The (-)-(11R,2′S)-enantiomer of the antimalarial drug mefloquine has been found to be a reasonably potent and moderately selective adenosine A2A receptor antagonist. Further investigation of this compound has led to the discovery of a series of keto-aryl thieno[3,2-d]pyrimidine derivatives, which are potent and selective antagonists of the adenosine A2A receptor. These derivatives show selectivity against the A1 receptor. Furthermore, some of these compounds have been shown to have in vivo activity in a commonly used model, suggesting the potential for the treatment of Parkinson's disease.
